The starting point for any UNITAID intervention is a public health problem (HIV/AIDS, tuberculosis, malaria) and insufficient access to commodities used to treat, diagnose, or prevent the problem.
|
UNITAID identifies market shortcomings (e.g., high prices, poor quality, inappropriate formulations, unavailability, etc.) that contribute to low commodity access and the reasons for these market shortcomings (e.g., lack of supplier competition, absence of incentives to develop critical but low profit products, etc.).
|
Through its partners, UNITAID develops and implements innovative market interventions to address the reasons for the market shortcomings.
|
Interventions are intended to yield short- term market impact that correct the market shortcomings (e.g., lower prices, better quality, improved formulation, increased availability, etc.), but also long term, sustainable market impact where manufacturers continue to invest & innovate and healthy competition drives markets towards public health goals.
|
The immediate public health impact of UNITAID interventions is an increased number of people with access to quality products. This increased coverage means more people live longer, healthier lives. Interventions are high value for money because UNITAID’s market impact extends to all countries, not just those receiving direct UNITAID support.
|